Research Articles | Page 12 | Aplastic Anemia and MDS International Foundation

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journalsort ascending Bone Marrow Disease
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes Oct 2015 Leukemia myelodysplastic syndromes (MDS)
Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodyspla Feb 2015 Leukemia myelodysplastic syndromes (MDS)
Comparison of clinical outcomes and prognostic utility of risk stratification tools in patients with therapy-related vs de novo myelodysplastic syndromes: a report on behalf of the MDS Clinical Research Consortium. Feb 2017 Leukemia myelodysplastic syndromes (MDS)
The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system Oct 2015 Leukemia myelodysplastic syndromes (MDS)
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials Oct 2016 Leukemia myelodysplastic syndromes (MDS)
Comparison of risk stratification tools in predicting outcomes of patients with higher-risk myelodysplastic syndromes treated with azanucleosides Oct 2015 Leukemia
Epigenetics of myelodysplastic syndromes Nov 2013 Leukemia myelodysplastic syndromes (MDS)
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes Jun 2017 Leukemia myelodysplastic syndromes (MDS)
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents Nov 2013 Leukemia myelodysplastic syndromes (MDS)
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes Oct 2015 Leukemia myelodysplastic syndromes (MDS)